Skip to main content

XenoTherapeutics Inc

Manchester, New Hampshire·EIN 81-1016095·NTEE G80 · Diseases, Disorders & Medical Disciplines·501(c)(3)·Filing year 2024

XenoTherapeutics Inc's highest-paid officer, the President & CEO, was reported at $168,557 for 2024 (IRS Form 990), including base pay and other compensation. Reported CEO pay ranged from $75,228 to $168,557 between 2023 and 2024.

Total revenue
$4.2M
Total assets
$1.8M
Total expenses
$3.1M
Reported officers
6

How XenoTherapeutics Inc’s pay compares

Compared with private foundations of similar size nationwide.

There were too few similar organizations to compare with, so this group goes beyond New Hampshire and covers all sectors.

Above peers

Most of the roles XenoTherapeutics Inc reports are paid above the middle half of what these private foundations pay for the same roles.

Show how each role compares

From the officer pay XenoTherapeutics Inc reported on its latest IRS Form 990.

Executive compensation

Form 990-PF · Part VIII · 2 reported individuals · Filing year 2024

Percentile bands compare each position's total pay with the same role at private foundations of similar size nationwide. There were too few similar organizations to compare with, so this group goes beyond New Hampshire and covers all sectors.

President & CEO
75th to 90th percentile
$169k
Treasurer & CFO
Above 90th percentile
$145k

Plus 4 unpaid individuals.

Browse compensation in Diseases, Disorders & Medical Disciplines →

Top pay as a share of expenses

In 2024, the highest total compensation at XenoTherapeutics Inc equaled 5% of the organization's total expenses. The median for diseases, disorders & medical disciplines organizations is 10%.

This organization (2024)
5%
Sector median
10%
Middle half of sector
4% to 22%

Based on 2,390 diseases, disorders & medical disciplines organizations, each measured at its most recent filing year with reported expenses and compensation.

Grants paid

Itemized grants reported on this foundation's 2024 Form 990-PF, Part XV.

Total granted

$0

Itemized grants

0

Up 93%
from 2023

From $87k in 2023 to $169k in 2024.

$87k
2023
$169k
2024
Pay for the position

Chief Executive Officer pay rose 124% from 2023 to 2024, while revenue rose 185%.

$75k in 2023 to $169k in 2024.
  • Chief Financial Officer pay rose 67% from 2023 to 2024.

Pay for the position itself, not any one person. The officeholder may have changed between 2023 and 2024.

Highest reported compensation in each year. Volunteer board members and partial-year payouts are filtered out.

Revenue and expenses over time

XenoTherapeutics Inc reported revenue and expenses across 2 filing years.

RevenueExpenses
$1.5M
$1.3M
2023
$4.2M
$3.1M
2024
Total revenue and total expenses from IRS Form 990 filings.

This is a private foundation. Peers are foundations of similar asset size ($1M–$10M), because foundation pay scales with assets under management, not revenue.

What the Chief Executive Officer earns at organizations like this one

The Chief Executive Officer at private foundations of similar size nationwide earns a median of $72,027.

25th percentile
$36k
Median
$72,027
75th percentile
$123k
90th percentile
$185k

These are pay figures for organizations like this one, not this organization's reported pay. Based on 649 organizations. There were too few similar organizations to compare with, so this group goes beyond New Hampshire and covers all sectors.

See full Diseases, Disorders & Medical Disciplines compensation data →

Common questions about XenoTherapeutics Inc

What does the Chief Executive Officer of XenoTherapeutics Inc earn?

In 2024, the Chief Executive Officer of XenoTherapeutics Inc received $168,557 in total compensation. This pay is in the top quarter for Chief Executive Officer roles among private foundations of similar size nationwide, though not the top 10% of comparable filings. Based on IRS Form 990 data.

How does Chief Executive Officer pay at XenoTherapeutics Inc compare with similar nonprofits?

Compared with the same role at private foundations of similar size nationwide, the 2024 pay of the Chief Executive Officer at XenoTherapeutics Inc falls between the 75th and 90th percentiles. In 2024, the highest total compensation at XenoTherapeutics Inc equaled 5% of the organization's total expenses. The median for diseases, disorders & medical disciplines organizations is 10%.

What are XenoTherapeutics Inc's revenue and expenses?

In 2024, XenoTherapeutics Inc reported $4.2M in total revenue and $3.1M in total expenses on its IRS Form 990.